
Al Musella, DPM President, Musella Foundation For Brain Tumor Research & Information, Inc.
-
October 1, 2020
How an Expert Would Treat His Own Glioblastoma
With: Al Musella, DPMTwo years ago, our Curious Dr. George asked Al Musella, DPM, what he would do if he were diagnosed with glioblastoma multiforme (GBM). Here, he revisits that question. Dr. Musella is President of the Musella Foundation For Brain Tumor Research… Read more »
-
September 17, 2018
Options to Treat a Glioblastoma
With: Al Musella, DPMPlease see our updated version of this article from Oct 1, 2020. A Q&A with Al Musella, DPM, President, Musella Foundation For Brain Tumor Research & Information, Inc., Hewlett, NY; email: musella@virtualtrials.com, phone: 888-295-4740 Q: You direct an established foundation… Read more »
-
July 16, 2018
Proposed FDA “Conditional Approval”- More Details
With: Marty Tenenbaum, PhDAl Musella, DPMA Q&A with Al Musella, DPM, President, Musella Foundation For Brain Tumor Research & Information, Inc., Hewlett, NY, and Marty Tenenbaum, PhD, Founder and Chair, Cancer Commons, Los Altos, CA Originally published May 10, 2017 Q: Your April 5, 2017 blog… Read more »
-
July 2, 2018
A Proposed New FDA Drug Approval Pathway: “Conditional”
With: Marty Tenenbaum, PhDAl Musella, DPMA Q&A with Al Musella, DPM, President, Musella Foundation For Brain Tumor Research & Information, Inc., Hewlett, NY, and Marty Tenenbaum, PhD, Founder and Chair, Cancer Commons, Los Altos, CA Originally published April 5, 2017 Q: The delay time from… Read more »